Press Releases
$MCW DISCLOSES NEW DETAILS ABOUT ITS PENDING TAKE PRIVATE: Mister Car Wash, Inc. Shareholders are notified that the company has revealed new details about the pending transaction which are relevant to BFA Law's ongoing investigation into LGP's $7.00 per share Take Private Transaction
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP notifies stockholders of Mister Car Wash, Inc. (NASDAQ: MCW) that new details have emerged related to BFA Law's ongoing investigation into the company's board of directors and its controlling stockholder, LGP, for potential breaches of their fiduciary duties to shareholders in connection with the pending take-private sale of Mister Car Wash that is slated to cash out every public stockholder for $7 per share. If you are a current shareholder of Mister Car Wash, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/mister-car-wash-investigation...
Fortinet Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortinet Inc. - FTNT
NEW YORK and NEW ORLEANS, April 3, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
BTGO Investors Have Opportunity to Join BitGo Holdings, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $BTGO--BTGO Investors Have Opportunity to Join BitGo Holdings, Inc. Fraud Investigation with the Schall Law Firm.
UPDATED: From Screen to Plate: CJ Foods' Cuisine. K Brings the Magic of Netflix Hit ‘Bon Appétit, Your Majesty' to U.S. Kitchens
Michelin-trained chefs kick off exclusive K-Drama cooking masterclasses in Los Angeles and New York City Michelin-trained chefs kick off exclusive K-Drama cooking masterclasses in Los Angeles and New York City
Payward Names Robert Moore as Chief Financial Officer
CHEYENNE, Wyo.--(BUSINESS WIRE)--Payward today announced the appointment of Robert Moore as Chief Financial Officer, effective immediately. Most executive searches answer the question in front of them: Who is available in the market with the right credentials? Payward asked a different question: Who already possesses the institutional knowledge of this company's financial history, and what would be the opportunity cost to replicate that with an external hire? The answer made the search unnecess...
NU E Power Corp. Retains Market Making Services
Calgary, Alberta--(Newsfile Corp. - April 3, 2026) - NU E Power Corp. (CSE: NUE) (OTC Pink: NUEPF) ("NU E" or the "Company") has, subject to regulatory approval, retained Venture Liquidity Providers Inc. ("VLP") to initiate its market-making service to provide assistance in maintaining an orderly trading market for the common shares of the Company. The market-making service will be undertaken by VLP through a registered broker, W.D...
Molina Healthcare Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Molina Healthcare, Inc. - MOH
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH). On July 23, 2025, the Company reported its financial results for the second quarter ended June 30, 2025 and cut its full-year 2025 earnings guidance, disclosing that “GAAP net income was $4.75 per dilut...
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS). On June 23, 2025, Novo Nordisk announced that it was terminating its partnership with Hims & Hers, disclosing that the Company had “failed to adhere to the law which prohibits mass sales of compounde...
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
BEDMINSTER, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that on April 2, 2026, it received a notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders' equity of at least $2.0 million if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years, Section 1003(a)(ii) of the Company Guide requiring a company to have stockholders' equity of at least $4.0 million if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years and Section 1003(a)(iii) of the Company Guide requiring a company to have stockholders' equity of at least $6.0 million if it has reported losses from continuing operations and/or net losses in its five most recent fiscal years. As of December 31, 2025, the Company had stockholders' equity of $4.83 million and has had losses in the most recent five fiscal years ended December 31, 2025. The Notice also indicates that the Company is not currently eligible for any exemption in Section 1003(a) of the Company Guide...
Lucid Announces Q1 Production & Deliveries, Sets Date for First Quarter 2026 Results
NEWARK, Calif., April 3, 2026 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ: LCID), maker of the world's most advanced software-defined vehicles and technologies, today announced production and delivery totals for the quarter ended March 31, 2026.
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on April 1, 2026, Anika granted restricted stock units (“RSUs”) covering an aggregate of 3,138 shares of common stock to one newly hired non-executive employee. The grant was made pursuant to the Anika Therapeutics, Inc. 2021 Inducement Plan, as amended, was approved by the compensation committee of the board of directors pursuant to a delegation of authority by the board of directors, and, in accordance with Nasdaq Listing Rule 5635(c)(4), was made as a material inducement to the grantee's acceptance of employment with Anika as a component of the grantee's employment compensation...
Jena Acquisition Corporation II Announces Non-Compliance with Section 802.01B of the NYSE Listed Company Manual which Requires the Company to Maintain a Minimum of 300 Public Stockholders
LAS VEGAS, NEVADA., April 03, 2026 (GLOBE NEWSWIRE) -- Jena Acquisition Corporation II (the “Company”) announced today that on April 1, 2026, the Company received a written notice from the staff of NYSE Regulation of the New York Stock Exchange (“NYSE”) indicating that the Company is not in compliance with Section 802.01B of the NYSE Listed Company Manual (the “Listing Rule”) which requires the Company to maintain a minimum of 300 public stockholders on a continuous basis...
Portland General Electric schedules earnings release and conference call for Friday, May 1
PORTLAND, Ore., April 3, 2026 /PRNewswire/ -- Portland General Electric Company (NYSE: POR) announced today that it will host an analyst conference call and webcast at 11 a.m.
Midland States Bancorp, Inc. To Announce First Quarter 2026 Financial Results On Thursday, April 23
EFFINGHAM, Ill., April 03, 2026 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (Nasdaq: MSBI) announced today that it will issue its first quarter 2026 financial results after market close on Thursday, April 23, 2026. Along with the press release announcing the financial results, the Company will publish an investor presentation that will be available on the Webcasts and Presentations page of its investor relations website...
BEASLEY BROADCAST GROUP TO REPORT FY 2025 FINANCIAL RESULTS, HOST CONFERENCE CALL AND WEBCAST ON APRIL 8
NAPLES, Fla., April 3, 2026 /PRNewswire/ -- Beasley Broadcast Group, Inc. (Nasdaq: BBGI) ("Beasley" or the "Company"), a multi-platform media company, announced today that it will report its FY 2025 financial results before the market opens on Wednesday, April 8, 2026.
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 03, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on April 1, 2026 (the “Grant Date”), ORIC granted a total of 80,000 non-qualified stock options and 15,000 restricted stock units to one new non-executive employee who began their employment with ORIC in March 2026...
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced that, effective April 1, 2026, the company granted non-qualified stock options to purchase 3,257 shares of its common stock to two new employees under Xilio Therapeutics' 2022 Inducement Stock Incentive Plan...
Bank of Hawai‘i Corporation Conference Call to Discuss First Quarter 2026 Financial Results and Board Declares Quarterly Preferred Stock Dividends
HONOLULU--(BUSINESS WIRE)--Bank of Hawai‘i Corporation (NYSE: BOH) (the “Company”) will release first quarter 2026 financial results on Monday, April 20, 2026 before the market opens and hold its quarterly conference call at 2:00 p.m. Eastern Time (8:00 a.m. Hawai‘i Time) on the same day. The live call, including a slide presentation, will be accessible on the investor relations link of the Company's website, www.boh.com. The webcast link is https://register-conf.media-server.com/register/BI42d...
AIOS Tech Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
HONG KONG, April 03, 2026 (GLOBE NEWSWIRE) -- AIOS Tech Inc. (NASDAQ: AIOS) (the “Company”), today announced that, on April 1, 2026, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that based on the closing bid price of the Class A Common Shares of the Company for the last 30 consecutive business days, the Company no longer meets the continued listing requirements of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share...
C1 Fund Inc. Announces Form N-CSR Filing Update
PALO ALTO, Calif.--(BUSINESS WIRE)--C1 Fund Inc. (NYSE: CFND) announced today that it is unable to complete and file its Annual Report on Form N-CSR and transmit its annual report to shareholders for the period ended December 31, 2025 within the prescribed time period without unreasonable effort or expense. The Fund has received notice from the New York Stock Exchange in connection with the late filing, which has no immediate effect on the listing of the Fund's common stock on the NYSE. As prev...
Shift4 Announces Fourth Dividend Date for Mandatory Convertible Preferred Stock
CENTER VALLEY, Pa.--(BUSINESS WIRE)---- $FOUR--Shift4 Payments, Inc. (“Shift4” or the “Company”) (NYSE: FOUR), announced today, in connection with the 10,000,000 shares of 6% Series A Mandatory Convertible Preferred Stock issued on May 5, 2025, consistent with the terms laid out in the offering, the Board of Directors has declared a dividend of $1.50 per share to be paid in cash on May 1, 2026 to holders of record as of the close of business on April 15, 2026. Subject to the terms of the Mandatory Conver...
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that on April 1, 2026, the Compensation Committee of Xeris' Board of Directors granted restricted stock units for an aggregate of 304,975 shares of its common stock to 90 new employee(s) under Xeris' Inducement Equity Plan. Xeris' Inducement Equity...
Kinsale Capital Group Announces First Quarter 2026 Earnings Release Date and Conference Call
RICHMOND, Va.--(BUSINESS WIRE)--Kinsale Capital Group Announces First Quarter 2026 Earnings Release Date and Conference Call.
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 (prabotulinumtoxinA) as a biosimilar to BOTOX (onabotulinumtoxinA) to achieve full-label U.S. market entry, today announced that, on April 2, 2026, in connection with the appointment of John Bencich as Chief Financial Officer, the Company's Compensation Committee of the Board of Directors (the “Compensation Committee”) approved the grant of inducement awards...
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that on April 1, 2026, it awarded inducement grants to 13 new employees under Intellia's 2024 Inducement Plan, as amended, as a material inducement to employment...
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
IRVINE, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 (prabotulinumtoxinA) as a biosimilar to BOTOX (onabotulinumtoxinA) to achieve full-label U.S. market entry, today announced that on March 31, 2026, it received a notice (the “Notice”) from NYSE American LLC (“NYSE American”) indicating that, following its year-end financial results, the Company is not in compliance with an additional continued listing standard set forth in the NYSE American Company Guide (the “Company Guide”)...
Spyre Therapeutics Announces Grants of Inducement Awards
WALTHAM, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease and rheumatic diseases, today announced that Spyre's independent Compensation Committee of the Board of Directors approved the grant of stock options to purchase an aggregate of 70,200 shares of common stock of Spyre to five non-executive employees as equity inducement awards under the Spyre Therapeutics, Inc. 2018 Equity Inducement Plan, as amended (the “2018 Plan”). The stock options were approved on April 1, 2026 and were material to each employee's acceptance of employment with Spyre, in accordance with Nasdaq Listing Rule 5635(c)(4)...
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on April 1, 2026, the Company granted inducement awards to purchase up to 228,500 shares of common stock to eight new employees under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and 1/48th of the underlying shares vesting monthly thereafter over 36 months, subject to the employee's continued service relationship with Syndax through the applicable vesting dates...
Arhaus Expands in Northern Virginia with New Ashburn Showroom
The artisan-crafted furnishings brand deepens its roots in Northern Virginia with a new showroom opening at One Loudoun
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (the “Company”) (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative γδ T cell therapies for cancer and autoimmune diseases, today announced that the Compensation Committee of the Company's Board of Directors granted two employees nonqualified stock options to purchase an aggregate of 11,800 shares of its common stock. The awards were approved by the Compensation Committee of the Company's Board of Directors and were granted outside of the Company's 2023 Equity Incentive Plan, with a grant date of April 1, 2026, as an inducement material to the new employees entering into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4)...
First Hawaiian to Report First Quarter 2026 Financial Results on April 24, 2026
HONOLULU, April 03, 2026 (GLOBE NEWSWIRE) -- First Hawaiian, Inc. (NASDAQ: FHB) announced today that it plans to release its first quarter 2026 financial results on Friday, April 24, 2026 before the market opens. First Hawaiian will host a conference call to discuss the company's results on the same day at 1:00 p.m. Eastern Time (7:00 a.m. Hawaii Time)...
Avidbank Holdings, Inc. to Announce First Quarter 2026 Earnings Results After-Market on Monday, April 27, 2026
SAN JOSE, CA / ACCESS Newswire / April 3, 2026 / Avidbank Holdings, Inc. (NASDAQ:AVBH) ("Avidbank Holdings") announced today that it will release first quarter 2026 earnings results on Monday, April 27, 2026, after the market closes. Upon release, investors may access a copy of the earnings results on the Avidbank website at www.avidbank.com under About Us, Investor Relations...
John Marshall Bancorp, Inc. Announces First Quarter 2026 Earnings Release Date
RESTON, Va.--(BUSINESS WIRE)--John Marshall Bancorp, Inc. (Nasdaq: JMSB) today announced that it expects to issue first quarter 2026 earnings before the market opens on Wednesday, April 29, 2026. About John Marshall Bancorp, Inc.: John Marshall Bancorp, Inc. is the bank holding company for John Marshall Bank. The Bank is headquartered in Reston, Virginia with eight full-service branches located in Alexandria, Arlington, Loudoun, Prince William, Reston, and Tysons, Virginia, as well as Rockville...
PHR Investors Have Opportunity to Join Phreesia, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $PHR--PHR Investors Have Opportunity to Join Phreesia, Inc. Fraud Investigation with the Schall Law Firm.
GRAL Investors Have Opportunity to Join GRAIL, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $GRAL--GRAL Investors Have Opportunity to Join GRAIL, Inc. Fraud Investigation with the Schall Law Firm.
RCM Technologies, Inc. Announces Fourth Quarter And Fiscal Year 2025 Results
PENNSAUKEN, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through the deployment of advanced engineering, specialty healthcare, and information technology services, today announced financial results for the fourteen and fifty-three weeks ended January 3, 2026...
Medline recognizes manufacturing facilities with Golden Cone Safety Award
NORTHFIELD, Ill., April 3, 2026 /PRNewswire/ -- Medline (Nasdaq: MDLN), the largest provider of medical-surgical products and supply chain solutions serving all points of care, announced this week its Golden Cone Awards to its top-performing manufacturing facilities in the U.S. These awards recognize Medline's seventeen manufacturing facilities in the United States across three size tiers based on employee count and hours worked, and are evaluated using monthly safety metrics, employee engagement in safety advocacy and awareness, and execution of an annual safety plan...
Shareholders who lost money in Vital Farms, Inc. (NASDAQ: VITL) Should Contact Wolf Haldenstein Immediately
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Vital Farms, Inc. (“Vital Farms” or the “Company”) (NASDAQ: VITL) securities during the period of May 8, 2025 through February 26, 2026, inclusive (“the Class Period”). Investors have until May 26, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit...
DBM Global to Pay Cash Dividend
PHOENIX, April 03, 2026 (GLOBE NEWSWIRE) -- DBM Global Inc. (“DBMG”), a family of companies providing fully integrated steel construction services, and an operating subsidiary of INNOVATE Corp. (NYSE: VATE), announced today that it will pay a cash dividend of approximately $3 million, or $0.78 per share, on April 28, 2026 to DBMG's stockholders of record at the close of business on April 13, 2026. About DBM Global Inc. DBMG is focused on delivering world class, sustainable value to its clients through a highly collaborative portfolio of companies which provide better designs, more efficient construction, and superior asset management solutions...
Weight Watchers Announces Leadership Transition and Board Updates
Office of the CEO Established to Oversee Business Operations Board Forms Transition Committee and Commences CEO Search NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced leadership and governance changes, including the establishment of an Office of the CEO and the formation of a new Transition Committee of the Board of Directors (“the Board”). These actions follow Tara Comonte's departure from the Company, effective March 31, 2026...
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WILMINGTON, Del., April 03, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), today announced that the Company granted non-qualified stock options to purchase up to an aggregate of 685,718 shares of the Company's common stock to five newly-hired non-executive employees under the Company's 2026 Inducement Equity Plan (the “Inducement Plan”), effective as of March 31, 2026 (the “Effective Date”). The inducement grants were previously approved by the Compensation Committee of the Company's Board of Directors, as a material inducement to the new employees' entry into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.68 per share, which is equal to the closing price of the Company's common stock on the Effective Date. The options have a ten year term, with 25% vesting on the first anniversary of the Effective Date and the remaining 75% vesting in 36 equal monthly installments thereafter. The options are subject to the terms and conditions of the Inducement Plan approved by the Company's Board of Directors in March 2026 and the terms and conditions of award agreements covering the grants...
Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans
HOUSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO) announced that its annual report(10-K) for the fiscal year ending December 31, 2025, filed on March 11, 2026, includes an audit opinion from Grassi & Co., CPAs, P.C. that contains a "going concern" qualification. This announcement is made pursuant to NYSE American LLC Company Guide Section 610(b), which requires public announcement of the receipt of an audit opinion containing a going concern paragraph and does not represent any change or amendment to the Company's financial statements for the year ended December 31, 2025...
Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)
SOUTH SAN FRANCISCO, Calif., April 03, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it has received notification from Takeda of its decision to terminate the collaboration agreement between the two companies to co-develop and co-commercialize DNL593 (PTV:PGRN). The decision was driven by strategic considerations and is not related to efficacy or safety data. DNL593 is an investigational progranulin replacement therapy utilizing Denali's Protein TransportVehicle™ (PTV) to deliver progranulin across the blood-brain barrier to the brain for the treatment of frontotemporal dementia-granulin (FTD-GRN). Denali has led development activities and will regain full control of DNL593 and its intellectual property portfolio...
Shareholders who lost money in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) Should Contact Wolf Haldenstein Immediately
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP informs investors that a securities fraud class action lawsuit has been filed against Aldeyra Therapeutics, Inc., (“Aldeyra” or the "Company") (NASDAQ: ALDX) on behalf of investors that bought securities between November 3, 2023 and March 16, 2026, inclusive (the “Class Period”). Investors have until May 29, 2026 to apply to the Court to be appointed as lead plaintiff in the lawsuit...
Ponce Bank Ranked Among Top 50 Best-Performing U.S. Community Banks by S&P Global Market Intelligence
BRONX, N.Y., April 03, 2026 (GLOBE NEWSWIRE) -- Ponce Bank, National Association, the banking subsidiary of Ponce Financial Group, Inc., has been recognized by S&P Global Market Intelligence as one of the Top 50 Best-Performing U.S. Community Banks of 2025 in the $3 billion to $10 billion asset category, ranking #40 nationally. This recognition underscores the Bank's strong financial performance while reaffirming its longstanding commitment to community impact and inclusive growth...
Moonbounce Launches with $12M to Give Organizations Real-Time Control Over AI Behavior
OAKLAND, Calif.--(BUSINESS WIRE)--Moonbounce, the AI control engine that ensures systems behave exactly as designed at any scale, today launched with $12 million in funding. Lead investors include Amplify Partners and StepStone Group (Nasdaq: STEP), with participation from angel investors PrimeSet and Josh Leslie, former CEO of Cumulus Networks and Gremlin. As generative AI scales across industries, traditional content moderation approaches based on retroactive review, rigid policies, and manua...
Former Sen. Sam Nunn Visits Ingalls Shipbuilding for Update on His Namesake Destroyer
PASCAGOULA, Miss., April 03, 2026 (GLOBE NEWSWIRE) -- HII's (NYSE: HII) Ingalls Shipbuilding division recently welcomed former U.S. Sen. Sam Nunn, his wife, Colleen Nunn, and their daughter and ship sponsor Michelle Nunn, for a visit to the shipyard. The visit included a construction update and tour of the future USS Sam Nunn (DDG 133), a Flight III Arleigh Burke-class destroyer named in honor of the senator, and marked their return to Ingalls following the ship's keel authentication ceremony...
Douglas Elliman Expands to California Wine Country with Global Real Estate Advisors and Top Producing Agents Christine Krenos and Joseph Zichelle
BEVERLY HILLS, Calif., April 3, 2026 /PRNewswire/ -- Douglas Elliman Realty, the preeminent luxury real estate brokerage in the United States, today announced its expansion into Northern California's coveted Wine Country, establishing a strong presence across the Napa and Sonoma markets.
Ridgetech, Inc. Announces 1-for-150 Reverse Share Split
HANGZHOU, China, April 3, 2026 /PRNewswire/ -- Ridgetech, Inc., a Cayman Islands exempted company (the "Company") (Nasdaq: RDGT), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that it expects to implement a 1-for-150 reverse share split on its ordinary shares ("Ordinary Shares") effective Tuesday, April 7, 2026 at 5:00 p.m. Eastern Time, with trading to begin on a split‑adjusted basis at the market open on the next trading day...
Sodexo - Monthly disclosure on share capital and voting rights on March 31, 2026
Regulated Information Issy-les-Moulineaux, April 3, 2026 Sodexo: Monthly disclosure on share capital and voting rights Pursuant to Article L.233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers Registered name of the issuer: SODEXO 255, quai de la Bataille de Stalingrad – 92130 ISSY-LES-MOULINEAUX Date Total number of shares Actual voting rights * Theoretical voting rights ** March 31, 2026 147,454,887 216,428,689 218,045,284 * Actual voting rights: all of the Company shares have the same voting rights, except for treasury shares which do not have voting rights and registered shares held for more than four years, which have double voting rights. ** Theoretical voting rights: the number of theoretical voting rights is calculated based on the shares having either single or double voting rights, including treasury shares which would normally be temporarily deprived of voting rights...
First Bank Announces First Quarter 2026 Earnings Conference Call
HAMILTON, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- First Bank (Nasdaq Global Market: FRBA) invites participation in a conference call to discuss the Company's financial and operating performance during its first quarter ending on March 31, 2026.
Biloxi Marsh Lands Corporation Announces Date of 2026 Annual Meeting of Shareholders, Results for the Fourth Quarter of 2025 and 12 Months ended December 31, 2025
METAIRIE, La.--(BUSINESS WIRE)--Biloxi Marsh Lands Corporation Announces Date of 2026 Annual Meeting of Shareholders, Results for the fourth quarter and year ended December 31, 2025.
GenSight Biologics Confirms Definitive Full-Year 2025 Consolidated Financial Results Are in Line with Estimates
PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today confirmed that its definitive annual results for the fiscal year ended 2025 are in line with the estimated figures published on March 27, 2026. Confirmation of Results The definitive consolidated and individual...
DEEP Robotics' Robot Dog Joins JD Logistics as “Cyber Tea Farmer” to Bridge First Kilometer of Spring Tea Harvest
HANGZHOU, China, April 03, 2026 (GLOBE NEWSWIRE) -- Spring tea season is here, and in Zhejiang's West Lake Longjing production area—one of China's most prized tea regions—DEEP Robotics has sent its robot dogs to work. The job? Hauling freshly picked tea leaves down the mountain so farmers don't have to. Together with JD Logistics, the quadruped robotics solutions are trying to crack a problem that's dogged premium tea production forever: getting delicate pre-Ming leaves off steep, narrow mountain paths and into the processing workshops fast enough. You've got about an hour before the leaves start losing what makes them special...
Geronimo Power Announces Start of Operations in Ohio at Dodson Creek Solar Project
117 MW PJM project located in Highland County MINNEAPOLIS, April 3, 2026 /PRNewswire/ -- Geronimo Power (Geronimo) announced today the start of commercial operations at its Dodson Creek Solar Project (Dodson Creek) in Highland County, Ohio. Located within the PJM market, Dodson will deliver 117 megawatts (MW) of power and generate an estimated $49 million in direct economic benefit for the local community...
SouthState Bank Corporation to Announce Quarterly Earnings Results on Thursday, April 23, 2026
WINTER HAVEN, Fla., April 3, 2026 /PRNewswire/ -- SouthState Bank Corporation (NYSE: SSB) ("SouthState" or the "Company") announced today that it will release first quarter 2026 earnings results on Thursday, April 23, 2026, after the market closes.
Dassault Aviation: Total number of shares and voting rights - 31 03 26
DASSAULT AVIATION French corporation ( société anonyme) with a share capital of 62,170,196.80 euros Headquarters: 78, quai Marcel Dassault 92210 SAINT-CLOUD 712 042 456 RCS Nanterre Information concerning the total number of voting rights and shares as per article L. 233-8 II of the French Commercial Code ( Code de commerce) and article 223-16 of the General Regulations ( Règlement Général) of the French Market Authority ( Autorité des Marchés Financiers) Date Total number of shares Total number of voting rights 03/31/2026 77,712,746 Theoretical voting rights: 129,926,031 Exercisable voting rights: 129,779,833 Attachment Total number of shares and voting rights - 31 03 26
The Fiber Weave Skew Problem Is Over: ACCM Celeritas™ SF1600 Delivers Zero-Skew for PCIe 7, 224 Gbps and Beyond
SAN JOSE, Calif.--(BUSINESS WIRE)--Advanced Chip & Circuit Materials, Inc. (ACCM) today introduced Celeritas SF1600, a laminate and prepreg material that eliminates fiber weave skew at its root. Fiber weave skew is a materials problem, not a routing one. Woven glass creates a spatially periodic dielectric in which differential pairs travel alternately through resin-rich and glass-rich regions. In a differential pair, the two conductors traverse different paths, which produces a time delay (...
NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements
Notifications have no immediate effect on the listing or trading of the Company's securities on Nasdaq Nasdaq has provided the Company until September 29, 2026 to regain compliance with both requirements The Company is actively evaluating actions to regain compliance, with a clear focus on initiatives that are aligned with and supportive of long-term shareholder value CAMBRIDGE, Mass., April 3, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd...
Stagwell (STGW) Doubles Down on AI Investment with Appointment of its First SVP, Enterprise AI Solutions
Driving go-to-market strategy for Stagwell's SaaS portfolio to help organizations unlock faster, smarter and more effective marketing NEW YORK CITY, NY / ACCESS Newswire / April 3, 2026 / Stagwell, the global challenger network transforming marketing through AI, today announced the appointment of Michael Twedell as the network's inaugural Senior Vice President, Enterprise AI Solutions. This appointment reinforces Stagwell's commitment to integrating unified solutions that serve complex enterprise needs while delivering practical tools for everyday marketers...
Newport Gold (NWPG) Finalizes Merger with NFI Empire
Primed for Scalable Growth as Clean, Streamlined OTC Public Company MISSISSAUGA, ON / ACCESS Newswire / April 3, 2026 / Newport Gold, Inc. (OTC.ID:NWPG) today announced it has entered the final stages of its merger with a trio of Pennsylvania Limited Liability Companies known as "NFI Empire" by entering into a formal Share Exchange Agreement. This Agreement is the product of NFI's disciplined, multi-year search for a public partner that met their strict structural and governance criteria...
DEADLINE NEXT WEEK: Berger Montague Advises Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) Investors to Contact the Firm Before April 6, 2026
PHILADELPHIA, April 3, 2026 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) ("Ultragenyx" or the "Company") on behalf of investors who purchased common shares of Ultragenyx during the period from August 3, 2023 through December 26, 2025 (the "Class Period"). Investor Deadline: Investors who purchased Ultragenyx securities during the Class Period may, no later than April 6, 2026 , seek to be appointed as a lead plaintiff representative of the class...
Eurofins Scientific SE: Director/PDMR Shareholding
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1. Details of the per...
Navient to announce first quarter 2026 results, host earnings webcast April 29
HERNDON, Va., April 03, 2026 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI) will host an audio webcast to review its first quarter 2026 results on Wednesday, April 29, 2026, at 8:00 a.m. Eastern Time.
HII Redelivers USS New Jersey (SSN 796) from Post-Shakedown Availability at Newport News Shipbuilding
NEWPORT NEWS, Va., April 03, 2026 (GLOBE NEWSWIRE) -- HII's (NYSE: HII) Newport News Shipbuilding division has completed post-shakedown availability (PSA) work on Virginia-class fast attack submarine USS New Jersey (SSN 796). The submarine was redelivered to the U.S. Navy Friday.
American Business Bank Announces Retirement of Jon Schlobohm From Board of Directors
LOS ANGELES--(BUSINESS WIRE)--American Business Bank Announces Retirement of Jon Schlobohm From Board of Directors.
Liberty Gold Advances Black Pine Permitting with Publication of a Federal Notice of Intent
VANCOUVER, British Columbia, April 03, 2026 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX: LGD; OTCQX: LGDTF) (“Liberty Gold” or the “Company”) is pleased to announce that the United States Forest Service (“USFS”) has published a Notice of Intent (“NOI”) in the Federal Register to prepare an Environmental Impact Statement (“EIS”) for the Company's Black Pine Oxide Gold Project (“Black Pine”) located in southeastern Idaho. The approval and publication of an NOI is the key permitting milestone that initiates the federal environmental review process for major projects under the National Environmental Policy Act (“NEPA”)...
Rhythm Pharmaceuticals Announces Changes to Board of Directors
-- Kim Popovits appointed as new Director; Ed Mathers to depart -- BOSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced changes to its Board of Directors, including the appointment of Kim Popovits and the departure of Ed Mathers...
Apogee Enterprises Announces Date for Fiscal 2026 Fourth Quarter and Full Year Results
MINNEAPOLIS--(BUSINESS WIRE)--Apogee Enterprises, Inc. (Nasdaq: APOG) a leading provider of architectural building products and services, as well as high-performance coated materials used in a variety of applications, today announced the company will report its fiscal 2026 fourth quarter and full year results on Friday, April 24, 2026, before the market opens. The Company will also host a conference call at 8:00 a.m. Central Time that day. Access to the live webcast will be available at https:/...
Hyundai Kicks Off FIFA World Cup™ "Next Starts Now" with Youth Camps Joined by Legends Mia Hamm and Tim Howard
Nationwide youth camps bring world-class soccer training to communities in Atlanta, Miami, New Jersey and Los Angeles Camps capture the heart of Hyundai's "Next Starts Now" campaign, celebrating the future, today, and inspiring the next generation of players and fans in the U.S. FOUNTAIN VALLEY, Calif., April 3, 2026 /PRNewswire/ -- Hyundai, an official partner of the 2026 FIFA World Cup™, is bringing its global commitment to soccer directly to local communities across the United States...
Choice Hotels International to Report First Quarter 2026 Earnings on April 30, 2026
NORTH BETHESDA, Md., April 3, 2026 /PRNewswire/ -- Choice Hotels International, Inc. (NYSE: CHH), a leading global lodging franchisor, today announced that it will report first quarter 2026 earnings results on Thursday, April 30, 2026, at approximately 6:30 a.m.
The Ultimate Editing Bay: GIBO Unveils Multi-Modal Workspaces Within GIBO Watch
KUALA LUMPUR, Malaysia, April 3, 2026 /PRNewswire/ -- GIBO Holdings Ltd. (NASDAQ: GIBO), a global technology company focused on AI-driven content, today announced the launch of its Multi-Modal Workspaces Engine, a core component of the GIBO Watch system designed to unify the editing, assembly, and finalization process for short-form video production...
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
BOSTON, April 03, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced it awarded an inducement grant on April 1, 2026 to one new employee under Bicara's 2026 Inducement Plan as a material inducement to employment...
Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026
RADNOR, Pa., April 3, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2026 financial results before the market opens on Wednesday, April 29, and will hold a conference call to discuss the results on the same day at 8:00 a.m...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DALLAS, April 03, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on April 1, 2026, the Compensation Committee of Taysha's Board of Directors granted four new employees, in the aggregate, restricted stock units (RSUs) representing 300,000 shares of the Company's common stock and an option to purchase 92,400 shares of the Company's common stock in connection with their employment. The RSUs and stock option were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4)...
Byline Bancorp, Inc. to Announce First Quarter 2026 Financial Results on Thursday, April 23
CHICAGO--(BUSINESS WIRE)--Byline Bancorp, Inc. (NYSE: BY) announced today that it will issue its first quarter 2026 financial results after market close on Thursday, April 23, 2026. Byline Bancorp will also host a conference call and webcast at 9:00 a.m. Central Time on Friday, April 24, 2026 to discuss its financial results. Analysts and investors may participate in the question-and-answer session. Conference Call, Replay and Webcast Information: Date: Friday, April 24, 2026 Time: 9:00 a.m. Ce...
AerCap Holdings N.V. to Release First Quarter 2026 Financial Results on April 29, 2026
DUBLIN, April 3, 2026 /PRNewswire/ -- AerCap Holdings N.V. ("AerCap" or the "Company") (NYSE: AER) today announced it will host a conference call and webcast for investors and analysts on Wednesday, April 29, 2026 at 8:30 a.m.
KB HOME OPENS LINWOOD AT MADERA RANCH: NEW HOMES FROM THE $370Ks IN MADERA, CALIFORNIA
New community walking distance to schools and parks is now open for tours. MADERA, Calif.
Lotus Showcases Emira Racing Line Edition at the New York International Auto Show
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (“Lotus Tech” or the “Company”) (Nasdaq: LOT), a leading global intelligent and luxury mobility provider, today announced that the Lotus brand will be represented at the New York International Auto Show, taking place April 3-12. The brand will showcase the latest Emira models, bringing Lotus' performance legacy to one of North America's most prominent automotive stages...
MBX Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CARMEL, Ind., April 03, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced the issuance of an equity inducement award to Karen Basbaum in connection with her commencement of employment as the company's new Chief Business Officer...
Bloomia Holdings, Inc. (TULP) Announces Preliminary Results of Rights Offering
MINNEAPOLIS, MN / ACCESS Newswire / April 3, 2026 / Bloomia Holdings, Inc. (Nasdaq:TULP) (the "Company"), a specialty agriculture company, today announced the preliminary results of its previously announced rights offering (the "Rights Offering"). The Rights Offering commenced in February 2026 and expired at 5:00 p.m...
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, April 03, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on April 1, 2026, the Compensation Committee of the Company's Board of Directors (the “Compensation Committee”) granted inducement awards consisting of nonstatutory stock options to purchase 153,750 shares of common stock to six (6) new employees under the Company's 2023 Inducement Option Plan, as amended. The Compensation Committee approved the stock options as an inducement material to such employees' employment in accordance with Nasdaq Listing Rule 5635(c)(4)...
MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (allo-iNKT) cell therapies to restore immune balance and treat immune-mediated diseases and cancer, today announced that data from an investigator-initiated Phase II trial at Memorial Sloan Kettering Cancer Center, evaluating agent-797, MiNK's allo-iNKT cell therapy, in combination with botensilimab (BOT) and balstilimab (BAL), will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 17-22, 2026, in San Diego, CA...
Agenus Announces Data from Phase II Study of BOT+BAL in Combination with agent-797 in PD-1 Refractory Gastroesophageal Cancer to be Presented at AACR 2026
LEXINGTON, Mass.--(BUSINESS WIRE)---- $AGEN #AACR2026--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that data from an investigator-initiated Phase II trial conducted at Memorial Sloan Kettering Cancer Center will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 17–22, 2026, in San Diego, CA. The study evaluates botensilimab (BOT) and balstilimab (BAL) in combination with agenT-797, an allogeneic iNKT cell therapy developed...
XCharge North America and JOJO Superfast EV Charging Launch New Midwest EV Charging Infrastructure
KYLE, Texas--(BUSINESS WIRE)--XCharge North America ("XCharge NA"), the North American subsidiary of XCHG Limited (Nasdaq: XCH) and a provider of high-power EV charging and battery-integrated solutions designed to strengthen the North American electrical grid, and JOJO Superfast EV Charging today announced a strategic partnership to deploy a high-power electric vehicle charging network across Illinois. Beyond manufacturing the chargers, XCharge NA will oversee every site from concept to complet...
Figure Technology Solutions Reports Preliminary March & Q1 2026 Operating Data
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Figure Technology Solutions (Nasdaq: FIGR; OPEN: FGRS), the leading blockchain-native capital marketplace for the origination, funding, sale, and trading of tokenized assets, today reported select preliminary operating data for the month and quarter ended March 31, 2026...
Multi-Sensor Data Labeling and AI Data Operations: What Enterprise AV Teams
Need to Know Research states the global data annotation tool market is projected to surpass $14 billion by 2034, with autonomous vehicles contributing to the increasing demand Why multi-sensor labeling across LiDAR, radar, and camera fusion is the defining technical challenge for autonomous vehicle data pipelines How human-in-the-loop annotation workflows maintain safety-critical quality at scale where automation alone falls short What enterprise AV teams should evaluate when selecting an AI data partner for autonomous vehicle programs VANCOUVER, British Columbia, April 03, 2026 (GLOBE NEWSWIRE) -- - Adoption rates are growing for the market of global data annotation tools, with autonomous vehicles (AV) and mobility accounting for the largest share of demand. As the market grows, enterprise AV teams building autonomous driving programs are confronting a challenge that model architecture alone cannot solve: training data quality...